Researchers at Cornell University have found that an FDA-approved drug used in human medicine can effectively treat oral squamous cell carcinoma in dogs, the most common oral epithelial cancer in canines. The study, which involved a team from five departments and institutes at Cornell, noted that the drug substantially inhibited tumor growth in both mouse models and dogs enrolled in a clinical trial. In one case during the trial, a dog’s tumor nearly disappeared within a few weeks.

According to Santiago Peralta, associate professor of dentistry and oral surgery in the Cornell University College of Veterinary Medicine, the findings provide a valuable clinical tool. The study was published on February 27 in Scientific Reports. Researchers highlight that the new treatment option may help dogs whose advanced cancer has metastasized, leaving surgery no longer feasible.

Source: Cornell University

Source Type: College

Source Location: Ithaca

Ithaca, NY

https://www.facebook.com/709174307912162/posts/1033867528776170

Lohmeyer Earns ESPN Ithaca Athlete of Week

WGOM Storm senior Gavin Lohmeyer earns ESPN Ithaca Athlete of Week honor.

Cornell Botanic Gardens: Must-See Spring Attraction

Cornell Botanic Gardens offer seasonal highlights and must-see spring attractions.

Cornell Develops AI-Powered Smart Workout Shirt

SeamFit is a smart shirt that tracks movements and counts exercises.

Cornell Students Study Late at Law Library

Cornell students study late at the Law School Library in Ithaca.

Global Firm, Cornell Tackle Drought Risk Assessment

Leading firm and Cornell study drought risks to better assess business impacts.

Cornell Asks: When Was A.D. White Statue Installed?

Cornell questions the installation date of the A.D. White statue on campus.

FYST Component Arrives at Cerro Chajnantor Peak

Submillimeter telescope component reaches high-altitude site after extensive journey.

Religious Leaders Aid Tanzania's Hypertension Fight

Religious leaders could help lower hypertension deaths in Tanzania and beyond.

Teen Schwartz Empowers Youth with Luxury Care

Isabelle Schwartz started a nonprofit distributing luxury beauty products to underprivileged youth.

Six Mile Creek Vineyard Launches Rosatto 2023 Rosé

Six Mile Creek Vineyard unveils Rosatto 2023 Rosé on a sunny outdoor deck.